NAV: 14 Feb 2025 | ₹19.06 |
Min. SIP amount | ₹100 |
Rating | 2 |
Fund size | ₹152.78Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 9.9% | 16.4% | 16.2% |
Category average | NA | 13.0% | 18.2% | NA |
Rank with in category | NA | 13 | 11 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 12.37% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 6.10% |
Cipla Ltd. | Healthcare | Equity | 5.74% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 5.61% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 5.26% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.07% |
Divi's Laboratories Ltd. | Healthcare | Equity | 4.93% |
Lupin Ltd. | Healthcare | Equity | 3.51% |
Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 3.13% |
AbbVie Inc | Healthcare | Forgn. Eq | 2.78% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 2.45% |
Novo Nordisk A/S - ADR | Healthcare | ADS/ADR | 2.33% |
Fortis Healthcare Ltd. | Healthcare | Equity | 2.32% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 2.26% |
Merck & Co Inc (US) | Healthcare | Forgn. Eq | 2.14% |
Thermo Fisher Scientific Inc. | Healthcare | Forgn. Eq | 1.95% |
Abbott Laboratories | Healthcare | Forgn. Eq | 1.90% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 1.80% |
Mankind Pharma Ltd. | Healthcare | Equity | 1.80% |
Novartis AG | Healthcare | ADS/ADR | 1.77% |
Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 1.74% |
Alkem Laboratories Ltd. | Healthcare | Equity | 1.57% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 1.52% |
Laurus Labs Ltd. | Healthcare | Equity | 1.51% |
Ipca Laboratories Ltd. | Healthcare | Equity | 1.49% |
Amgen Inc. (USA) | Healthcare | Forgn. Eq | 1.31% |
Danaher Corporation | Healthcare | Forgn. Eq | 1.24% |
Stryker Corp | Healthcare | Forgn. Eq | 1.15% |
Biocon Ltd. | Healthcare | Equity | 1.12% |
Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 1.04% |
Piramal Pharma Ltd. | Healthcare | Equity | 1.04% |
Vertex Pharmaceuticals Inc. (USA) | Healthcare | Forgn. Eq | 1.02% |
Medtronic | Healthcare | Forgn. Eq | 1.00% |
Syngene International Ltd. | Healthcare | Equity | 1.00% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 0.91% |
Ajanta Pharma Ltd. | Healthcare | Equity | 0.87% |
Gland Pharma Ltd. | Healthcare | Equity | 0.84% |
Suven Pharmaceuticals Ltd. | Healthcare | Equity | 0.79% |
Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 0.62% |
Regeneron Pharmaceuticals Inc | Healthcare | Forgn. Eq | 0.62% |
Global Health Ltd. | Healthcare | Equity | 0.62% |
Becton Dickinson And Co | Healthcare | Forgn. Eq | 0.61% |
Agilent Technologies Inc | Healthcare | Forgn. Eq | 0.37% |
Iqvia Holdings | Healthcare | Forgn. Eq | 0.31% |
Illumina Inc. (USA) | Healthcare | Forgn. Eq | 0.18% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Min. for 1st investment | ₹100 |
Min. for 2nd investment onwards | ₹100 |
Min. for SIP | ₹100 |